MX2009002356A - Composiciones farmaceuticas que comprenden clopidogrel. - Google Patents
Composiciones farmaceuticas que comprenden clopidogrel.Info
- Publication number
- MX2009002356A MX2009002356A MX2009002356A MX2009002356A MX2009002356A MX 2009002356 A MX2009002356 A MX 2009002356A MX 2009002356 A MX2009002356 A MX 2009002356A MX 2009002356 A MX2009002356 A MX 2009002356A MX 2009002356 A MX2009002356 A MX 2009002356A
- Authority
- MX
- Mexico
- Prior art keywords
- clopidogrel
- pharmaceutical formulations
- melt granulate
- pharmaceutically acceptable
- melt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Granulado de fundición en la forma de una dispersión en estado sólido del fármaco en un portador farmacéuticamente aceptable, en donde dicho granulado de fundición comprende un compuesto farmacéuticamente activo, preferiblemente clopidogrel, por lo menos un material portador, y opcionalmente excipientes farmacéuticamente aceptables y método de hacer dicho granulado de fundición.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06019429A EP1900358A1 (en) | 2006-09-16 | 2006-09-16 | Pharmaceutical formulations comprising clopidogrel |
PCT/EP2007/008070 WO2008031623A1 (en) | 2006-09-16 | 2007-09-17 | Pharmaceutical formulations comprising clopidogrel |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009002356A true MX2009002356A (es) | 2009-05-15 |
Family
ID=37735123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009002356A MX2009002356A (es) | 2006-09-16 | 2007-09-17 | Composiciones farmaceuticas que comprenden clopidogrel. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20090270448A1 (es) |
EP (3) | EP1900358A1 (es) |
AT (1) | ATE552826T1 (es) |
AU (1) | AU2007296854A1 (es) |
CA (1) | CA2663311A1 (es) |
DE (1) | DE202007019385U1 (es) |
DK (1) | DK2068838T3 (es) |
ES (1) | ES2384740T3 (es) |
IL (1) | IL197089A0 (es) |
MX (1) | MX2009002356A (es) |
NO (1) | NO20091467L (es) |
NZ (1) | NZ575153A (es) |
PL (1) | PL2068838T3 (es) |
PT (1) | PT2068838E (es) |
RU (1) | RU2009114206A (es) |
WO (1) | WO2008031623A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004106344A2 (en) | 2003-04-25 | 2004-12-09 | Cadila Healthcare Limited | Salts of clopidogrel and process for preparation |
EP1900358A1 (en) | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Pharmaceutical formulations comprising clopidogrel |
CN102240269B (zh) * | 2010-05-12 | 2013-04-10 | 天津泰普药品科技发展有限公司 | 结晶型硫酸氢氯吡格雷片剂的制备方法 |
EP2585161A1 (en) * | 2010-06-23 | 2013-05-01 | Stefan Kralev | Medical device for self-administration of patients with acute coronary events |
CN107501289B (zh) * | 2017-09-07 | 2019-06-14 | 山东齐都药业有限公司 | 硫酸氢氯吡格雷有关物质d的制备方法 |
CN110339178B (zh) * | 2019-06-28 | 2021-07-02 | 广州白云山天心制药股份有限公司 | 一种硫酸氢氯吡格雷固体制剂的制备方法 |
CN115737578A (zh) * | 2022-11-23 | 2023-03-07 | 石家庄四药有限公司 | 一种硫酸氢氯吡格雷阿司匹林复方片及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2530247B1 (fr) | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
US5308621A (en) * | 1991-02-18 | 1994-05-03 | Commonwealth Scientific And Industrial Research Organisation | Ascorbic acid composition and transdermal administration method |
JP3397385B2 (ja) * | 1993-09-20 | 2003-04-14 | 第一製薬株式会社 | 崩壊遅延防止錠剤 |
KR100768034B1 (ko) * | 1999-03-17 | 2007-10-17 | 다이이찌 세이야꾸 가부시기가이샤 | 의약 조성물 |
FR2792836B3 (fr) * | 1999-04-30 | 2001-07-27 | Sanofi Sa | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
CA2363053C (en) | 2001-11-09 | 2011-01-25 | Bernard Charles Sherman | Clopidogrel bisulfate tablet formulation |
DE10305984A1 (de) * | 2003-02-13 | 2004-09-02 | Helm Ag | Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen |
DE10341264A1 (de) * | 2003-09-04 | 2005-03-24 | Grünenthal GmbH | Schmelzformulierte, multipartikuläre orale Darreichungsform |
EP1900358A1 (en) * | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Pharmaceutical formulations comprising clopidogrel |
-
2006
- 2006-09-16 EP EP06019429A patent/EP1900358A1/en not_active Withdrawn
-
2007
- 2007-09-17 EP EP07818184A patent/EP2068838B1/en not_active Not-in-force
- 2007-09-17 CA CA002663311A patent/CA2663311A1/en not_active Abandoned
- 2007-09-17 AT AT07818184T patent/ATE552826T1/de active
- 2007-09-17 RU RU2009114206/15A patent/RU2009114206A/ru unknown
- 2007-09-17 PL PL07818184T patent/PL2068838T3/pl unknown
- 2007-09-17 NZ NZ575153A patent/NZ575153A/en not_active IP Right Cessation
- 2007-09-17 WO PCT/EP2007/008070 patent/WO2008031623A1/en active Application Filing
- 2007-09-17 PT PT07818184T patent/PT2068838E/pt unknown
- 2007-09-17 MX MX2009002356A patent/MX2009002356A/es active IP Right Grant
- 2007-09-17 EP EP11003617A patent/EP2359810A2/en not_active Withdrawn
- 2007-09-17 AU AU2007296854A patent/AU2007296854A1/en not_active Abandoned
- 2007-09-17 US US12/441,501 patent/US20090270448A1/en not_active Abandoned
- 2007-09-17 ES ES07818184T patent/ES2384740T3/es active Active
- 2007-09-17 DE DE202007019385U patent/DE202007019385U1/de not_active Expired - Lifetime
- 2007-09-17 DK DK07818184.9T patent/DK2068838T3/da active
-
2009
- 2009-02-17 IL IL197089A patent/IL197089A0/en unknown
- 2009-04-15 NO NO20091467A patent/NO20091467L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PT2068838E (pt) | 2012-06-27 |
EP2359810A2 (en) | 2011-08-24 |
AU2007296854A1 (en) | 2008-03-20 |
ES2384740T3 (es) | 2012-07-11 |
EP2068838B1 (en) | 2012-04-11 |
EP2068838A1 (en) | 2009-06-17 |
US20090270448A1 (en) | 2009-10-29 |
PL2068838T3 (pl) | 2012-10-31 |
IL197089A0 (en) | 2009-11-18 |
NZ575153A (en) | 2011-01-28 |
ATE552826T1 (de) | 2012-04-15 |
DK2068838T3 (da) | 2012-07-09 |
EP1900358A1 (en) | 2008-03-19 |
RU2009114206A (ru) | 2010-10-27 |
CA2663311A1 (en) | 2008-03-20 |
NO20091467L (no) | 2009-04-15 |
DE202007019385U1 (de) | 2012-03-29 |
WO2008031623A1 (en) | 2008-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009002356A (es) | Composiciones farmaceuticas que comprenden clopidogrel. | |
WO2008014175A3 (en) | Granular pharmaceutical compositions | |
WO2007081948A3 (en) | Bioadhesive drug formulations for oral transmucosal delivery | |
HK1081855A1 (en) | Administration form for pharmaceutically active peptides with sustained release and method for the production thereof | |
HK1126671A1 (en) | Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same | |
HK1190909A1 (zh) | 用於鼻淚系統的藥物釋放方法、結構及組合物 | |
EP1783137A4 (en) | GALACTOSIS DERIVATIVE, DRUG VECTOR AND THERAPEUTIC PREPARATION | |
IL183357A0 (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form | |
MY150626A (en) | Fast dissolving solid dosage form | |
MX2010004366A (es) | Materiales inmiscibles en agua como vehiculos para suministro de farmacos. | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
HRP20090194T1 (en) | Dry granulated composition comprising emtricitabine and tenofovir df | |
MX2008012731A (es) | Tabletas de paracetamol de liberacion rapida. | |
MY148237A (en) | Pharmaceutical compositions comprising nilotinib or its salt | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
WO2008101173A3 (en) | Biodegradable compositions and materials | |
ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
WO2007016350A3 (en) | Modified release tablet formulations with enhanced mechanical properties | |
HK1120417A1 (en) | Stable nanoparticle formulations | |
AU2003268386A1 (en) | Controlled drug release tablets | |
IS7383A (is) | Skammtaform með stýrða lyflosun til inngjafar | |
WO2011062936A3 (en) | Self-assembled toroidal-spiral particles and manufacture and uses thereof | |
ES2169980A1 (es) | Microcapsulas para la liberacion prolongada de farmacos. | |
PT1499278E (pt) | Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa | |
WO2007119249A3 (en) | Pharmaceutical compositions of cefixime |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |